Cara Therapeutics Has Risen ~18% in January(Continued from Prior Part)Earnings trendsIn the first nine months of 2018, Cara Therapeutics (CARA) reported a net income and EPS of -$53.4 million and -$1.54, respectivelyâcompared to -$43.9 million and